| 中文名 | 1-((2R,3r,4r,5r)-5-((双(4-甲氧基苯基)(苯基)甲氧基)甲基)-4-羟基-3-甲氧基四氢呋喃-2-基)嘧啶-2,4(1h,3h)-二酮 |
|---|---|
| 英文名 | 1-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-3-methoxyoxolan-2-yl]pyrimidine-2,4-dione |
| 中文别名 |
5'-O-(4,4'-二甲氧基三苯基甲基)-2'-甲氧基尿苷
DMT保护性-2'-甲氧基尿苷 |
| 英文别名 |
DMT-2'-OMe-U
5'-O-DMT-2'-O-METHYL-URIDINE 5'-DMT 2'-O-methyl uridine 2'-O-methyl-5"-O-dimethoxytrityl uridine HG1364 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-O-methyl-uridine 2'-O-Methyl-5'-O-DMT-Uridine;DMT-2'-OMe-U |
| 描述 | 5'-O-(4,4'-二甲氧基三苯基)-2'-O-甲基尿苷是尿苷类似物。尿苷具有潜在的抗癫痫作用,其类似物可用于研究抗惊厥和抗焦虑活性,以及开发新的抗高血压药物[1]。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 分子式 | C31H32N2O8 |
|---|---|
| 分子量 | 560.59 |
| 精确质量 | 560.21600 |
| PSA | 121.24000 |
| LogP | 2.83580 |
| 外观性状 | Powder | White to Pale Yellow |
| 储存条件 | Store dry at 2-8°C |
|
~65%
103285-22-9 |
| 文献:Buettner, Lea; Seikowski, Jan; Wawrzyniak, Katarzyna; Ochmann, Anne; Hoebartner, Claudia Bioorganic and Medicinal Chemistry, 2013 , vol. 21, # 20 p. 6171 - 6180 |
|
~99%
103285-22-9 |
| 文献:ISIS Pharmaceuticals, Inc. Patent: US5914396 A1, 1999 ; |
|
~90%
103285-22-9 |
| 文献:Barbeyron, Renaud; Wengel, Jesper; Vasseur, Jean-Jacques; Smietana, Michael Monatshefte fur Chemie, 2013 , vol. 144, # 4 p. 495 - 500 |
|
~%
103285-22-9 |
| 文献:Bioorganic and Medicinal Chemistry, , vol. 21, # 20 p. 6171 - 6180 |
|
~%
103285-22-9 |
| 文献:Bioorganic and Medicinal Chemistry, , vol. 21, # 20 p. 6171 - 6180 |